The final MBRG identified in this study was ADAM9. Overexpression of ADAM9, a zinc metalloproteinase expressed on the cell surface, is thought to be associated with the clinicopathological features of HCC leading to tumorigenesis, invasion, metastasis, and poor prognosis [62]. This evidence concerns the gene ADAM9 and hepatocellular carcinoma.